KalVista Pharmaceuticals, Inc.
(KALV - NASDAQ)
19,16 USD
📋 Profilo Aziendale

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs.

|